Navigation Links
FDA Issues Letter to Sunovion Pharmaceuticals, Claims Patient Brochures Made by Company to Support Its Respiratory Drug Brovana Mislead, Parker Waichman LLP Notes
Date:11/1/2013

New York, New York (PRWEB) November 01, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices, is noting that the U.S. Food and Drug Administration (FDA) has made allegations in a letter sent to Sunovion Pharmaceuticals on Oct. 24, 2013, that patient brochures made by the drug maker to support its respiratory drug Brovana are misleading in that they overstate the drug’s efficacy, make unsubstantiated claims, and minimize risks associated with the drug.

The FDA also alleges in its letter to Sunovion that the drug maker was promoting Brovana in a deceptive manner by downplaying references to the drug’s risks, which include a black-box warning of potential fatalities for some asthma patients, while highlighting in big, bold fonts the drug’s benefits. The brochures, the FDA letter further notes, also exaggerate the drug’s effectiveness by claiming it could help patients “resume their baseline activities of daily living.” Such claims were precluded by results of clinical studies, the letter notes, which found that Brovana produced an improvement of about 10 percent in the volume of air that patients can exhale during a forced breath.

“Drug makers need to be especially diligent when producing promotional material for the general public; keeping people informed with the best available information is always the proper solution,” says Gary Falkowitz, Managing Attorney at Parker Waichman LLP. “The FDA is doing exactly what they are supposed to. In view of that fact, we believe it is only appropriate for us to look at what is going on here a little more deeply.”

Parker Waichman is currently evaluating cases to determine whether a class action lawsuit is appropriate.

Marlborough, Mass.-based Sunovion Pharmaceuticals Inc., a unit of Osaka, Japan-based Dainippon Sumitomo Pharma Co. Ltd., received approval for its respiratory drug Brovana (generic name: arformoterol tartrate) by the FDA on Oct. 6, 2006, as noted on the FDA’s website, last updated on Feb. 19, 2012. Described as an “inhalation solution,” Brovana was approved for the treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, the FDA’s letter to Sunovion notes. Meant for long-term, twice daily (mornings and evenings) use, the drug is taken via a nebulizer only, says the letter.

If you or a loved one took the prescription drug Brovana, you may have valuable legal rights. To find out more about joining a Brovana class action lawsuit, please visit our website or contact one of our experienced class action lawyers today at 1(800)-LAW-INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary P. Falkowitz, Managing Attorney
1+ (800) LAW-INFO
1+ (800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/fda_letter_brovana/11/prweb11294652.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCSF chancellor issues call-to-arms to patient advocates
2. Radiologists rank themselves as less than competent on health policy issues
3. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
4. FDA Issues Multiple Sclerosis Drug Alert
5. Quality of care, other issues may cause worse results in black prostate cancer surgery patients
6. U.S. Task Force Issues Blood Pressure Guidelines
7. Internists in Washington to discuss patient and professional issues in meetings on Capitol Hill
8. Cheaper drug could lead to serious eye issues
9. Insulite Labs announces the launch of the PCOS Inspiration Hour, a one hour virtual gathering place for women with PCOS and other women’s health issues to come together.
10. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
11. What Men Should Know About Veins: Varicose Veins and Venous Disease are Real Medical Issues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2019)... ... July 18, 2019 , ... ... Deutsch is featured in Atlanta, Magazine’s list of “Top Doctors” issue. Deutsch is ... and reconstructive surgery, experience. With specialized training from MD Anderson Cancer Center and ...
(Date:7/17/2019)... ... July 17, 2019 , ... The FDA has ... capable of treating up to eight body areas simultaneously. Dr. Dennis Dass ... much faster and easier than previous muscle toning devices or conventional exercise. , “The ...
(Date:7/17/2019)... ... July 17, 2019 , ... Dynamic Healthcare Systems, ... Advantage, Medicaid, and Marketplace programs is pleased to announce the introduction of an ... (EHR) integration at the point of care to providers and provider groups ...
(Date:7/17/2019)... ... 17, 2019 , ... Athena Software , a leading ... worldwide, has been awarded a California Multiple Award Schedules (CMAS) agreement by the ... and local government agencies in California by designating pre-approved suppliers from whom they ...
(Date:7/17/2019)... ... July 17, 2019 , ... The Coalition of Medication-Assisted Treatment ... seven of its member Opioid Treatment Programs (OTPs) at 12 locations are participating ... virus (HCV) with the goal of achieving better outcomes through telemedicine. The study, ...
Breaking Medicine News(10 mins):
(Date:7/19/2019)... Calif. (PRWEB) , ... July 19, 2019 , ... Today, ... L.M.F.T., is proud to announce the expansion of The Missing Peace with the opening ... the Brain opens its doors July 19, 2019. , The Missing Peace ...
(Date:7/18/2019)... ... July 18, 2019 , ... Joining PAINWeek, the largest ... two 2-hour courses on Saturday, September 7. PAINWeek faculty members James Fricton, DDS, ... IMS Board Member and Pain Specialist, will lead these skills training courses, Transformative ...
(Date:7/18/2019)... ... July 18, 2019 , ... Phlexglobal today ... meeting regulatory guidelines and achieve optimum TMF Health. , United Kingdom Lunch ... will host two Lunch and Learn events to present information about the new ...
Breaking Medicine Technology: